Transient Protein States in Designing Inhibitors of the MDM2-p53 Interaction
- 1 December 2013
- Vol. 21 (12) , 2143-2151
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Stapled α−helical peptide drug development: A potent dual inhibitor of MDM2 and MDMX for p53-dependent cancer therapyProceedings of the National Academy of Sciences, 2013
- Lithocholic acid is an endogenous inhibitor of MDM4 and MDM2Proceedings of the National Academy of Sciences, 2012
- Activation of the p53 pathway by small-molecule-induced MDM2 and MDMX dimerizationProceedings of the National Academy of Sciences, 2012
- Interrogation of MDM2 Phosphorylation in p53 Activation Using Native Chemical Ligation: The Functional Role of Ser17 Phosphorylation in MDM2 ReexaminedJournal of the American Chemical Society, 2012
- The Structure‐Based Design of Mdm2/Mdmx–p53 Inhibitors Gets SeriousAngewandte Chemie International Edition, 2011
- Binding Induced Folding in p53−MDM2 ComplexJournal of the American Chemical Society, 2007
- GROMACS: Fast, flexible, and freeJournal of Computational Chemistry, 2005
- An exact mathematical expression for describing competitive binding of two different ligands to a protein moleculeFEBS Letters, 1995
- The CCP4 suite: programs for protein crystallographyActa Crystallographica Section D Structural Biology, 1994
- Comparison of simple potential functions for simulating liquid waterThe Journal of Chemical Physics, 1983